2022
DOI: 10.1016/j.bpj.2021.11.1787
|View full text |Cite
|
Sign up to set email alerts
|

Investigating the role of l-asparaginase as a potential therapeutic target against gonorrhea infections

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4

Citation Types

1
4
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(5 citation statements)
references
References 0 publications
1
4
0
Order By: Relevance
“…FDA‐approved drugs Pemirolast and thalidomide appeared among the top hits. Interestingly, the same drugs were reported earlier by us as potent N. gonorrhoeae L‐asparaginase (NgA) inhibitors 30,31 . Interestingly, the data from our previous study highlights complete growth inhibition with pemirolast and thalidomide.…”
Section: Discussionsupporting
confidence: 80%
See 4 more Smart Citations
“…FDA‐approved drugs Pemirolast and thalidomide appeared among the top hits. Interestingly, the same drugs were reported earlier by us as potent N. gonorrhoeae L‐asparaginase (NgA) inhibitors 30,31 . Interestingly, the data from our previous study highlights complete growth inhibition with pemirolast and thalidomide.…”
Section: Discussionsupporting
confidence: 80%
“…Interestingly, the same drugs were reported earlier by us as potent N. gonorrhoeae L-asparaginase (NgA) inhibitors. 30,31 Interestingly, the data from our previous study highlights complete growth inhibition with pemirolast and thalidomide. However, the action of another drug decitabine, which specifically targets only Lasparaginase, showed comparatively less inhibition.…”
Section: Discussionmentioning
confidence: 84%
See 3 more Smart Citations